Clinical Guides
Meningitis: Emergency Assessment and Early Management
A source-grounded emergency guide to suspected meningitis in India, emphasising immediate stabilisation, time-critical investigation and treatment, local antimicrobial stewardship, and a clear boundary between community-acquired bacterial disease and other central nervous system infections.
MedNext Academy | 16 min read
Meningitis: Emergency Assessment and Early Management
A source-grounded emergency guide to suspected meningitis in India, emphasising immediate stabilisation, time-critical investigation and treatment, local antimicrobial stewardship, and a clear boundary between community-acquired bacterial disease and other central nervous system infections.
Summary
Meningitis is inflammation of the meninges, most often caused by infection, and it can deteriorate into sepsis, cerebral oedema, seizures, shock or neurological injury within hours. The working diagnosis is clinical: fever, headache, neck stiffness, altered mental state, photophobia, vomiting, seizures, focal deficit or a non-blanching rash may occur, but their absence does not safely exclude the condition. Infants may instead present with poor feeding, irritability, abnormal temperature, lethargy, bulging fontanelle or seizures. WHO treats suspected acute bacterial meningitis as a medical emergency requiring care in an appropriate facility. [WHO fact sheet, Diagnosis and Treatment, accessed 2026-08-21.]
The first operational rule is to avoid a false choice between testing and treatment. Obtain blood cultures and, when safe and immediately available, cerebrospinal fluid (CSF); neither lumbar puncture nor imaging should delay the first antimicrobial dose when bacterial meningitis is suspected. WHO recommends intravenous ceftriaxone or cefotaxime as empiric treatment in children older than one month and adults, with ampicillin or amoxicillin added when Listeria risk factors are present. Vancomycin is added only where local pneumococcal resistance data justify it. [WHO 2025, Recommendation 1, pp. 35–36.] This is a teaching guide, not a pre-authorised prescription chart: the exact drug, dose, renal adjustment, allergy alternative and infusion plan must be checked against the current hospital protocol and microbiology advice.
Give intravenous corticosteroid with the first antibiotic dose when the non-epidemic bacterial-meningitis pathway supports it; WHO identifies dexamethasone as the preferred corticosteroid for children and adults and advises a maximum four-day course only when bacterial CSF findings or susceptible organisms support continuation. [WHO 2025, Recommendation 9 and remarks, pp. 54–56.] Urgently involve senior emergency, paediatric, obstetric, infectious-diseases, neurology and critical-care teams according to age, pregnancy, immune status and severity.
How Common Is It?
Meningitis is uncommon compared with routine febrile illness, but its consequences make delayed recognition unacceptable. WHO states that bacterial meningitis can cause long-term complications in about one in five affected people, including hearing loss, learning or behavioural difficulty; the burden is especially high in low- and middle-income settings. [WHO 2025, Overview, p. 1; WHO fact sheet, Treatment.] That global statement is not an Indian incidence estimate. Published counts vary with laboratory capacity, blood-culture and CSF collection before antibiotics, surveillance definitions, epidemic activity and access to hospital care. A service should not convert data from another country into a local risk percentage.
In India, the practical epidemiology is shaped by age, vaccination coverage, outbreaks, tuberculosis prevalence, HIV and other immunosuppression, seasonal infections and the capacity to obtain prompt microbiology. Acute community-acquired bacterial meningitis is not interchangeable with tuberculous, cryptococcal, viral, post-neurosurgical or shunt-associated meningitis. These conditions differ in investigation, isolation and therapy. ICMR’s antimicrobial guideline explicitly says that acute bacterial meningitis treatment must exclude tuberculosis and Cryptococcus as alternatives. [ICMR 2019, Table 11.3, p. 138.]
The useful clinical denominator is therefore the person in front of the team: a febrile patient with meningism, altered consciousness, seizure, purpura, shock, focal neurology or unexplained severe headache. In a district or hospital without immediate CSF microscopy, the delay to transfer, blood culture, antibiotics and neurological monitoring should be audited. Counts of “meningitis” without organism, timing of antibiotics or outcome do not reveal whether the service is safe. Every survivor also needs a sequelae plan, because an apparently uncomplicated discharge can miss hearing, cognitive, motor, seizure and psychosocial needs. [WHO 2025, Recommendations 15–20, pp. 86–101.]
Risk Factors
Risk is determined by host, exposure and route into the central nervous system. Very young infants, older adults, people with impaired splenic function, complement deficiency, CSF leak, cochlear implant, recent head trauma, neurosurgery, a CSF shunt, malignancy, HIV, immunosuppressive therapy or diabetes need a lower threshold for senior assessment. Pregnancy and the early postpartum period require immediate obstetric and infectious-diseases collaboration because maternal sepsis, fetal considerations and medicine choices cannot be inferred from a non-pregnant adult pathway. A newborn has a separate pathogen spectrum and must never be treated by copying adult content. WHO’s 2025 guideline covers community-acquired meningitis in people older than one month, adolescents and adults; neonatal disease falls outside that scope. [WHO 2025, Scope, pp. 1–2.]
Exposure history changes the differential. Ask about household or institutional contact with meningococcal disease, recent upper respiratory illness, crowding, travel, vaccination history, animal and water exposures, TB contact, headache duration, rash, sick contacts and recent antimicrobials. Document otitis, mastoid symptoms, sinus symptoms, pneumonia, endocarditis risk, skull fracture, spinal procedure and skin infection. Immunocompromise broadens the differential and makes a negative early test less reassuring.
Listeria risk is not an age label alone. WHO asks clinicians to consider older age, pregnancy, immunocompromise and other local epidemiology when deciding whether to add ampicillin or amoxicillin to initial therapy. [WHO 2025, Recommendation 1 remarks, p. 36.] Do not assume that every pregnant patient, older adult or immunocompromised patient receives the same regimen; check the local protocol, documented allergy and renal function before prescribing.
Medication history is safety-critical. Record recent antibiotics, steroids, anticoagulants, antiplatelets and immunosuppressants, plus non-prescription and traditional medicines. These may alter culture yield, procedural bleeding risk, glucose, renal function or the differential diagnosis. The right response is not reflexive withholding: it is documented senior decision-making linked to the planned lumbar puncture, imaging and treatment sequence.
Diagnosis
Diagnosis has three simultaneous aims: recognise a time-critical syndrome, establish the cause and identify complications that alter immediate care. Treating a patient who looks septic or neurologically unstable is not contingent on completing a diagnostic checklist. WHO states that lumbar puncture is needed to examine CSF, but must never delay antibiotic treatment when bacterial meningitis is suspected. [WHO fact sheet, Diagnosis, accessed 2026-08-21.]
History
Establish onset and speed of progression; fever; severe or new headache; neck pain or stiffness; photophobia; vomiting; confusion; drowsiness; seizure; focal weakness; rash; respiratory symptoms; diarrhoea; ear or sinus disease; trauma; surgery; CSF leak and contact history. Ask specifically about pregnancy or postpartum status, immune suppression, HIV care, TB contact, previous meningitis, vaccination and recent antimicrobial exposure. In an infant, ask about feeding, alertness, irritability, abnormal cry, temperature instability and seizures rather than waiting for classical neck stiffness.
Examination
Document airway, breathing, circulation, glucose, temperature, blood pressure, oxygen saturation, conscious level and pupils before a prolonged neurological examination. Look for purpura or petechiae, shock, meningism, focal deficit, cranial nerve signs, papilloedema if assessable, dehydration and a potential ear, sinus, chest, skin or line source. Repeated observations matter more than one reassuring assessment. Deteriorating consciousness, seizure, shock, respiratory failure or rapidly spreading rash mandates resuscitation and critical-care escalation.
Investigations
Take blood cultures and relevant blood tests promptly if this does not delay antimicrobials. CSF opening pressure, cell count and differential, protein, glucose with paired blood glucose, Gram stain, culture and local molecular tests should be requested when lumbar puncture is safe. Blood culture and molecular testing can remain informative after an early dose, but do not use that possibility to defer sampling. CT before lumbar puncture is a risk-based decision made by the treating senior team; a scan is not a screening ritual and should not create an antibiotic delay. Interpret CSF alongside timing, blood results and microbiology; partial treatment, TB, cryptococcosis and viral disease can produce overlapping patterns. [WHO 2025, Recommendations 2–7, pp. 40–51.]
Differential Diagnosis
The immediate differential includes acute bacterial meningitis with or without meningococcal sepsis, viral meningoencephalitis, tuberculosis of the central nervous system, cryptococcal meningitis, malaria and other regionally relevant febrile encephalopathies, brain abscess, cerebral venous thrombosis, subarachnoid haemorrhage, severe migraine, toxic-metabolic encephalopathy and sepsis without meningeal infection. The question is not simply “meningitis or not”; it is whether an untreated bacterial process, encephalitis, raised intracranial pressure or shock is present now.
Altered behaviour, seizure or focal deficit should broaden consideration to encephalitis, stroke, abscess and venous thrombosis. A prolonged or subacute course, weight loss, cranial neuropathy, pulmonary symptoms, immune compromise or very high opening pressure shifts concern towards TB or cryptococcal disease. In India, it is unsafe to collapse all chronic meningitis into “TB” without CSF, imaging and microbiological reasoning, and equally unsafe to use a short bacterial course for suspected TB or cryptococcal infection. ICMR flags TB and Cryptococcus as exclusions in the acute bacterial pathway. [ICMR 2019, Table 11.3, p. 138.]
Sepsis with rash must be treated as a possible invasive meningococcal syndrome until assessed. A rash may be absent, and purpura can occur in other disorders; it is a trigger for escalation, not a microbiological diagnosis. Do not let “viral symptoms” or a normal initial white count override a declining conscious level, shock or convincing meningism.
State the working diagnosis and the uncertainty explicitly: for example, “suspected community-acquired bacterial meningitis; TB and encephalitis remain possible; antibiotics given at time X; CSF pending.” This reduces handover error and prevents premature de-escalation. Definitive therapy follows organism identification and susceptibility, not a one-size-fits-all completion date. [WHO 2025, Recommendations 10–12, pp. 60–73.]
Management
Start with resuscitation and parallel task allocation. Secure airway and oxygenation when required, obtain intravenous access, correct immediately reversible hypoglycaemia, treat shock according to the current sepsis and critical-care pathway, draw blood cultures if this causes no delay, and give the first empiric antibiotic without waiting for imaging or CSF when bacterial meningitis is suspected. WHO recommends intravenous ceftriaxone or cefotaxime for initial empiric treatment in children over one month and adults; add ampicillin or amoxicillin for Listeria risk factors, and add vancomycin only where resistant pneumococci are a demonstrated local problem. [WHO 2025, Recommendation 1 and remarks, pp. 35–36.]
Do not reproduce a dose from a teaching guide onto a drug chart. The ICMR adult and paediatric guidance lists ceftriaxone or cefotaxime plus ampicillin for Listeria coverage, with vancomycin in its acute bacterial meningitis pathway, but local resistance patterns, age, weight, renal function, allergy, formulation and pharmacy advice determine the actual order. [ICMR 2019, Table 11.3, p. 138; paediatric bacterial meningitis text, pp. 81–85.] Obtain an infectious-diseases or microbiology opinion early if there is anaphylaxis history, pregnancy, severe immunocompromise, recent neurosurgery, a device, non-response or an unusual CSF profile.
Administer intravenous corticosteroid with the first antibiotic dose in the WHO non-epidemic bacterial-meningitis pathway when no contraindicating condition exists. Stop it if CSF is not compatible with bacterial meningitis; its continuation depends on organism and CSF findings. WHO advises that corticosteroids should not be routinely used in meningococcal epidemics. [WHO 2025, Recommendation 9, pp. 54–56.] Manage seizures under the current seizure protocol, monitor conscious level and cardiorespiratory status, and seek critical-care support early for shock, refractory seizure, falling consciousness or ventilation need.
Review at set intervals: culture and PCR results, susceptibility, CSF pattern, drug exposure, renal function, glucose, fluids, seizures, hearing plan and source control. Narrow therapy only with microbiological and clinical agreement. ICMR gives broad duration ranges, but organism, complication, response and specialist advice determine the individual duration. [ICMR 2019, pp. 84–85, 138.]
Prescribing Information
This section deliberately separates verified principles from a bedside prescription. For suspected community-acquired bacterial meningitis in people older than one month and adults, WHO recommends intravenous ceftriaxone or cefotaxime as initial empiric treatment; ampicillin or amoxicillin is added when Listeria risk factors are present. Vancomycin is added when the prevalence of penicillin- or third-generation-cephalosporin-resistant pneumococci is high. [WHO 2025, Recommendation 1, pp. 35–36.] The exact dose, frequency, maximum, infusion compatibility and renal or hepatic adjustment are not safely portable across adult, paediatric, neonatal, pregnant, dialysis and critically ill populations. They must be verified in the current local formulary before administration.
ICMR’s 2019 guidance provides an Indian reference for syndrome-level selection and notes that therapy becomes pathogen-directed after identification. It describes ceftriaxone or cefotaxime with ampicillin for Listeria coverage and vancomycin in empiric acute bacterial meningitis; it lists 10–14 days as a general range and a longer duration for Listeria or Gram-negative infection. [ICMR 2019, Table 11.3, p. 138.] It is a 2019 national guidance document, not evidence that a particular ward’s susceptibility pattern is unchanged in 2026. Prescribers should obtain the hospital antibiogram and microbiology advice rather than broaden empirically by habit.
WHO recommends intravenous corticosteroids with the first antibiotic dose in eligible non-epidemic suspected bacterial meningitis; dexamethasone is the preferred option for children and adults, and continuation is limited to a maximum of four days when CSF or pathogen findings support it. [WHO 2025, Recommendation 9, pp. 54–56.] ICMR reports a dexamethasone schedule in its bacterial-meningitis text, but its use is not recommended in neonates. [ICMR 2019, p. 84.] This age distinction is a reason to involve paediatrics, not to extrapolate an adult schedule.
Before every dose, document allergy phenotype, last antimicrobial exposure, creatinine and urine output, weight in children, pregnancy status, line access and the plan for culture review. Check vancomycin monitoring and any interaction or adjustment in the local monograph. A medication list without those safeguards is not safe prescribing.
When to Refer
Suspected bacterial meningitis warrants immediate hospital-level care; referral is an active process, not a delayed outpatient appointment. Send the first antibiotic dose if referral delay is expected and local policy permits, then transfer with a written record of time of symptom onset, observations, glucose, blood cultures, drugs and fluids given, allergy history, pregnancy status and deterioration. WHO calls meningitis a medical emergency requiring urgent attention in an appropriate health-care facility. [WHO fact sheet, Treatment.]
Escalate immediately to emergency senior review and critical care for shock, purpura, persistent seizure, deteriorating conscious level, focal deficit, severe respiratory compromise, suspected raised intracranial pressure, recurrent vomiting, rapidly worsening headache or inability to protect the airway. Refer early to a centre with imaging, lumbar puncture, microbiology, paediatrics, obstetrics, neurology/neurosurgery and intensive care when these are unavailable locally. Do not postpone transfer to complete a non-essential test.
Involve infectious diseases or microbiology for resistant-organism risk, documented immediate beta-lactam anaphylaxis, pregnancy, HIV or other marked immunosuppression, post-neurosurgical or device-associated disease, persistent fever, a discordant CSF pattern, positive blood culture or failure to improve. Involve public-health teams through the local process when meningococcal disease is suspected or confirmed, because contact assessment and prophylaxis are public-health actions, not an unsupervised family prescription. WHO notes that close contacts of meningococcal disease may receive antibiotics to eradicate carriage and reduce transmission. [WHO fact sheet, Antibiotics for prevention.]
Before discharge, arrange hearing assessment and neurological, rehabilitation, developmental, mental-health and social follow-up where indicated. WHO recommends assessment for sequelae before discharge and during follow-up. [WHO 2025, Recommendations 15–20, pp. 86–101.]
Red Flags
Treat the following as immediate escalation triggers rather than diagnostic trivia: rapidly worsening headache; fever with altered mental status; neck stiffness with vomiting or photophobia; seizure; new focal neurological deficit; purpuric or petechial rash; cold peripheries or hypotension; rapidly falling consciousness; respiratory compromise; persistent or recurrent seizure; severe agitation with confusion; and suspected meningitis in a very young infant, pregnant person, older adult or immunocompromised person. These features demand monitoring, resuscitation capability and a time-stamped treatment plan. [WHO fact sheet, Signs and symptoms; WHO 2025, acute-care recommendations.]
A “normal” early examination, no rash, no documented fever or a short duration does not remove risk. Infants often present differently from adults, and WHO specifically notes differing infant symptoms. [WHO fact sheet, Signs and symptoms.] A patient with a severe headache and meningism after recent antimicrobial exposure may have altered CSF or culture findings; a patient with apparent viral illness can have bacterial disease or encephalitis. Reassessment is essential.
Red flags after antibiotics are equally important: ongoing shock, new or recurrent seizures, oxygen requirement, declining Glasgow Coma Scale, focal signs, signs of fluid overload, worsening renal function, persistent bacteraemia, non-response at 24–48 hours or a CSF result inconsistent with the working diagnosis. ICMR advises repeat CSF in selected non-responders, resistant infections treated with adjunctive dexamethasone and neonates, while routine repeat CSF is not needed in an improving patient. [ICMR 2019, pp. 84–85.]
Never use red flags to justify indefinite broad-spectrum therapy. They justify senior reassessment, repeat examination, source review, imaging or microbiological reassessment as appropriate. The safety endpoint is a documented explanation for the ongoing syndrome and a monitored plan, not simply another dose.
Indian Clinical Context
Indian practice needs both speed and stewardship. The ICMR treatment guideline provides a national syndrome-level acute bacterial meningitis pathway and explicitly requires exclusion of TB and Cryptococcus; it recommends ceftriaxone or cefotaxime with ampicillin for Listeria coverage and vancomycin in the listed empiric regimen. [ICMR 2019, Table 11.3, p. 138.] This establishes a national reference, not a substitute for the hospital’s current antibiogram, drug stock, paediatric formulary or specialist network. Resistance, laboratory turnaround and access differ materially between facilities.
The safest local workflow records whether blood cultures and CSF were obtained before antibiotics, the time to first dose, the local meningococcal isolation and notification process, the reason for any deviation from protocol, organism and susceptibility, complications and sequelae referral. WHO identifies surveillance, laboratory confirmation and antimicrobial-resistance monitoring as core control functions. [WHO fact sheet, Surveillance.] Hospitals should link their meningitis pathway to infection-prevention and public-health teams rather than relying on ad-hoc corridor advice.
TB, cryptococcal disease and viral encephalitis are especially important competing diagnoses in Indian settings. The aim is not to make every acute case a TB work-up before treatment; it is to send appropriate CSF and blood tests, document the differential and change therapy once evidence warrants it. A long subacute course, immunosuppression, cranial neuropathy or discordant CSF should prompt specialist input.
Access matters clinically. If CT, CSF microscopy, PCR, ICU, paediatric critical care or antimicrobials are not available, arrange early transfer after stabilisation and first-dose treatment under protocol. Families should receive an explanation in a language they understand, including why a spinal tap may be needed, why the first antibiotic cannot wait, what complications to watch for and how follow-up will be arranged. This improves consent and continuity without creating false reassurance.
NMC Competency Mapping
This guide supports integration rather than memorisation. For an MBBS learner, the core task is to recognise a potentially life-threatening central nervous system infection, obtain a focused history and examination, identify sepsis and neurological deterioration, interpret basic CSF and blood results with supervision, and communicate a clear escalation plan. It links Microbiology with Medicine, Paediatrics, Pharmacology, Emergency Medicine, Community Medicine and AETCOM. The mapping should be checked against the institution’s current NMC CBME curriculum and local competency ledger rather than invented from a generic code list. [NMC, Competency-Based Medical Education Curriculum 2024, programme and subject documents.]
A suitable observed case discussion asks the learner to say what must happen in the first minutes, which samples can be taken without delaying treatment, when a lumbar puncture might be unsafe or deferred, why age and immune status matter, and how microbiology alters empiric therapy. A medication-order exercise must require the learner to open the local formulary and record weight, allergy, renal function and administration route; recall of a dose alone is not prescribing competence.
For a simulation, assess recognition of deteriorating consciousness, shock, rash or seizure; closed-loop communication; time-stamped cultures and antibiotics; safe transfer; and escalation to seniors. A learner should not independently select an antimicrobial regimen for neonates, pregnancy, anaphylaxis, renal failure, device-associated infection or suspected TB/cryptococcal meningitis. These are deliberately supervised decisions.
The professionalism component includes avoiding stigma around HIV or TB, explaining urgent treatment and lumbar puncture respectfully, documenting uncertainty, notifying the correct public-health pathway where indicated, and arranging hearing and disability follow-up. The educational goal is a safe first response and a defensible handover, not counterfeit confidence.
Key Exam Pearls for NEET PG
Meningitis questions often test pattern recognition, but clinical safety comes first. Classic adult features are fever, headache, neck stiffness and altered mental status; infants may have a less classical presentation. A lumbar puncture provides CSF evidence, yet suspected bacterial meningitis must receive antibiotics without waiting for lumbar puncture results. [WHO fact sheet, Signs and symptoms; Diagnosis and Treatment.]
Know the distinction between syndrome and organism. Acute community-acquired bacterial meningitis, TB meningitis, cryptococcal meningitis, viral meningoencephalitis and post-neurosurgical disease have different differentials and management pathways. ICMR’s acute bacterial pathway specifically reminds clinicians to exclude TB and Cryptococcus. [ICMR 2019, Table 11.3, p. 138.] A CSF profile is a probability tool, not a licence to ignore chronology, prior antimicrobials or immune status.
For empiric therapy, the high-yield principle is coverage matched to age, Listeria risk and local resistance—not memorising one universal cocktail. WHO recommends ceftriaxone or cefotaxime first line for children older than one month and adults; add ampicillin or amoxicillin when Listeria risk factors are present, and add vancomycin in settings with demonstrated high resistant-pneumococcal prevalence. [WHO 2025, Recommendation 1, pp. 35–36.]
Dexamethasone is adjunctive, not a reason to delay antibiotics. WHO recommends intravenous corticosteroid with the first antibiotic dose in eligible non-epidemic suspected bacterial meningitis and identifies dexamethasone as the preferred agent for children and adults; continuation is guided by CSF and pathogen results. [WHO 2025, Recommendation 9, pp. 54–56.] Finally, remember the survivor: hearing, cognitive, neurological and psychosocial sequelae need planned follow-up. [WHO 2025, Recommendations 15–20, pp. 86–101.]
Frequently Asked Questions
Should lumbar puncture wait until after antibiotics are started?
No. Obtain CSF before antibiotics when it is safe and immediately feasible, but suspected bacterial meningitis is an emergency and lumbar puncture must never delay the first antibiotic dose. Record the sequence, time of blood cultures, neurological status and reason for any deferral. [WHO fact sheet, Diagnosis; WHO 2025, Recommendations 2–7.]
Is one empirical antibiotic regimen safe for every meningitis patient?
No. Age, neonatal status, pregnancy, immune status, Listeria risk, local resistance, allergy, renal function, recent neurosurgery and device status all change the safe pathway. WHO describes principles for community-acquired disease over one month; use the current institutional protocol and specialist input for the individual order. [WHO 2025, Scope and Recommendation 1.]
When should dexamethasone be given in suspected bacterial meningitis?
In eligible non-epidemic suspected bacterial meningitis, WHO recommends intravenous corticosteroid with the first antibiotic dose, not after a prolonged delay. Dexamethasone is the preferred corticosteroid for children and adults; continuation depends on CSF and pathogen findings, and treatment should not be routinely used in meningococcal epidemics. [WHO 2025, Recommendation 9, pp. 54–56.]
What follow-up is needed after a patient survives meningitis?
Assess for hearing loss, cognitive, developmental, neurological, seizure, functional and psychosocial consequences before discharge and during follow-up. The appropriate referrals depend on age and deficits. WHO recommends sequelae assessment and multidisciplinary support; do not assume a normal bedside conversation excludes hearing or learning difficulty. [WHO 2025, Recommendations 15–20, pp. 86–101.]
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic